Prostate cancer (PCa) is a highly prevalent disease that affects men's health worldwide and
is the second most common malignancy in males. Ferroptosis is a novel form of …

For nearly 50 years, immunotherapy has been used in patients with bladder cancer in the
form of Mycobacterium bovis Bacillus Calmette-Guerin (BCG), which is still the first-line …

Uterine corpus endometrial carcinoma (UCEC) is a malignant disease globally, and there is
no unified prognostic signature at present. In our study, two clusters were identified. Cluster …

Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Guérin (BCG) is
the standard treatment for non-muscle invasive bladder cancer (NMIBC) patients and …

Background Although immunotherapy is effective in improving the clinical outcomes of
patients with bladder cancer (BC), it is only effective in a small percentage of patients …

目的探讨125 I 粒子植入放疗对前列腺癌免疫微环境的影响. 方法利用免疫组织化学技术检测,
比较cT 1~ 3 N 0 M 0 期前列腺癌行125 I 粒子植入治疗前, 后前列腺癌细胞PD-L1 表达情况 …

The stromal component of the tumour microenvironment in primary and metastatic prostate
cancer can influence and promote disease progression. Within the prostatic stroma …

Prostate cancer (PCa) is the most common malignant tumor and the second leading cause
of cancer-related mortality in men worldwide. Despite significant advances in PCa therapy …

Background The systemic immune-inflammation index (SII) is a cost-efficient indicator for
carcinoma prognosis. However, its utility in urothelial carcinoma (UC) prognosis is disputed …

Neoadjuvant therapies can improve tolerability, reduce tumor volume to facilitate surgery,
and assess subsequent treatment response. Therefore, there is much enthusiasm for …